Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Brian M, Watson"'
Autor:
Brian M. Watson, Julia Bullard
Publikováno v:
Proceedings of the Association for Information Science and Technology. 59:335-345
Publikováno v:
Cataloging & Classification Quarterly. 60:599-619
Autor:
Brian M. Watson
Publikováno v:
The American Archivist. 85:315-319
Publikováno v:
Proceedings of the Association for Information Science and Technology. 58:582-586
Autor:
Sarah Stein Lubrano, Brian M. Watson
Publikováno v:
Archives of Sexual Behavior. 50:1225-1238
We present the results of an investigation into the biographies, letters, and archives of approximately 50 well-known figures in Western intellectual and artistic history in the post-Enlightenment era. In this article, in the interest of space, we ha
Autor:
Brian M. Watson
Publikováno v:
The American Archivist. 84:222-226
Autor:
Brian M. Watson
Publikováno v:
Porn Studies. 8:201-223
The goal of this article is to ‘bring’ reddit and its user communities into porn and information studies and to argue that its unique features offer insights and have implications for both fields. ...
Autor:
Brian M. Watson
Publikováno v:
Journal of Intellectual Freedom & Privacy. 4:19-28
Reviewing every issue of “Censorship Dateline” in the Newsletter on Intellectual Freedom and Journal of Intellectual Freedom and Privacy alongside ALA Office for Intellectual Freedom’s annual reports on censorship and the EBSCO ban in Utah, thi
Autor:
Brian M. Watson
Publikováno v:
The American Archivist. 83:187-190
Autor:
Brian A. Willis, Stephen L. Lowe, Scott A. Monk, Patrick J. Cocke, Christopher D. Aluise, Leonard N. Boggs, Anthony R. Borders, Richard A. Brier, Robert A. Dean, Steven J. Green, Douglas E. James, Stanford S. Jhee, Qun Lin, Albert C. Lo, Patrick C. May, Brian M. Watson, Leonard L. Winneroski, Zhixiang Yang, Jennifer A. Zimmer, David L. McKinzie, Dustin J. Mergott
Publikováno v:
Journal of Alzheimer's disease reports. 6(1)
Background: The development of beta-site amyloid-beta precursor protein cleaving enzyme (BACE) 1 inhibitors for the treatment of Alzheimer’s disease requires optimization of inhibitor potency, selectivity, and brain penetration. Moreover, there is